Thromb Haemost 1987; 58(03): 806-810
DOI: 10.1055/s-0038-1645994
Original Article
Schattauer GmbH Stuttgart

The Effects of Human Thrombomodulin on the Inactivation of Thrombin by Its Serum Inhibitors

E Anne Thompson
Department of Medicine, Monash Medical School, Prahran, Victoria, Australia
,
Hatem H Salem
Department of Medicine, Monash Medical School, Prahran, Victoria, Australia
› Author Affiliations
Further Information

Publication History

Received 04 March 1987

Accepted after revision 28 April 1987

Publication Date:
28 June 2018 (online)

Summary

Thrombomodulin is an endothelial cell protein which accelerates thrombin-dependent protein C activation by over 1000 fold. In this study, the effect of thrombomodulin on the inactivation of thrombin by its serum inhibitors was evaluated.

125I-thrombin was incubated at 37° C with serum and the resulting complexes separated by SDS-PAGE. Antithrombin III was the major complex formed with some 125I-thrombin bound to heparin cofactor II and highermolecular weight fractions. Inclusion of thrombomodulin at increasing concentrations inhibited 125I-thrombin binding to antithrombin III and the higher molecular weight fractions but had little effect on thrombin-heparin cofactorII complex formation. Similar results were obtained using a purified antithrombin III/heparin cofactor II system.

Kinetic studies, using purified antithrombin III, revealed that thrombomodulin acts as a weak competitive inhibitor towards antithrombin III (Ki = 39 nM).

We postulate that in the microcirculation, where the ratio of thrombomodulin to antithrombin III is relatively high, thrombin bound to thrombomodulin may be protected from inactivation by antithrombin III and can thus promote efficient activation of protein C.

 
  • References

  • 1 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane bound cofactor for thrombin catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
  • 2 Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin catalyzed fibrin formation and factor V activation. J Biol Chem 1982; 257: 7944-7947
  • 3 Esmon NL, Carroll RC, Esmon CT. Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 1983; 258: 12238-12242
  • 4 Maruyama I, Salem HH, Ishii H, Majerus PW. Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin. J Clin Invest 1985; 75: 987-991
  • 5 Mann KG, Lundblad RL. Biochemistry of thrombin. In: Hemostasis and thrombosis. Colman RW, Hirsh J, Marder VJ, Salzman EW. ed. Pennsylvania: JB Lippincott Co.; 1982: 112-126
  • 6 Salem HH. The natural anticoagulants. Clinics in Haematoloev 1986; 15: 371-391
  • 7 Jakubowski HV, Kline MD, Owen WG. The effect of bovine thrombomodulin on the specificity of bovine thrombin. J Biol Chem 1986; 261: 3876-3882
  • 8 Bourin MC, Boffa MC, Bjork I, Lindahl U. Functional domains of rabbit thrombomodulin. Proceedings of the National Academy of Sciences 1986; 83: 5924-5928
  • 9 Hofsteenge J, Taguchi H, Stone SR. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem J 1986; 237: 243-251
  • 10 Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on human platelets. J Biol Chem 1978; 253: 6908-6916
  • 11 Owen WG. Evidence for the formation of an ester between thrombin and heparin cofactor. Biochim Biophys Acta 1975; 405: 380-387
  • 12 Griffith MJ, Noyes CM, Church FC. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J Biol Chem 1985; 260: 2218-2225
  • 13 Salem HH, Maruyama I, Ishii H, Majerus PW. Isolation and characterisation of thrombomodulin from human placenta. J Biol Chem 1984; 259: 12246-12251
  • 14 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bateriophage T4. Nature 1970; 227: 680-685
  • 15 Suzuki K, Kusumoto H, Hashimoto S. Isolation and characterisation of thrombomodulin from bovine lung. Biochim Biophys Acta 1986; 882: 343-352
  • 16 Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258: 6713-6716
  • 17 Marcum JA, Rosenberg RD. Anticoagulantly active heparin like molecules from vascular tissues. Biochemistry 1984; 23: 1730-1737
  • 18 Rosenberg RD. Actions and interactions of antithrombin and heparin. New Engl J Med 1975; 292: 146-151
  • 19 Buonassissi V. Sulfated mucopolysaccharide synthesis and secretion in endothelial cell cultures. Exp Cell Res 1973; 76: 363-368